Mohammad Shahrokh Esfahani
Stanford Medicine(US)Stanford University(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Genetic factors in colorectal cancer
Most-Cited Works
- → Determining cell type abundance and expression from bulk tissues with digital cytometry(2019)4,724 cited
- → Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling(2017)1,048 cited
- → Integrating genomic features for non-invasive early lung cancer detection(2020)667 cited
- → Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients(2016)655 cited
- → Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma(2018)480 cited
- → Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA(2016)474 cited
- → Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition(2020)355 cited
- → Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA(2021)343 cited
- → The landscape of tumor cell states and ecosystems in diffuse large B cell lymphoma(2021)293 cited
- → Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer(2019)269 cited